Javascript must be enabled to continue!
TO DETERMINE THE EXPRESSION OF E-CADHERIN IN DIFFERENT HISTOLOGICAL SUBTYPES OF AMELOBLASTOMA FOR GAUGING AND PREDICTING THE AGGRESSIVENESS AND BEHAVIOR OF THIS TUMOR IN OUR POPULATION
View through CrossRef
Objective: The current study is designed to determine the expression of immunohistochemical markers E-Cadherin in different histological subtypes of ameloblastoma for gauging and predicting the aggressiveness and behavior of this tumor in our population.
Materials and Methods: A total of 60 cases of ameloblastoma were collected for this study from June2016 to June 2017, in AFIP Rawalpindi. The tumor was sub-classified histologically on the basis of WHO classification. Final results were analyzed. Mean and standard deviation were calculated for quantitative variables. Frequency and percentages were calculated for qualitative variables. Chi square test was applied to find the association of E-Cadherin with histological variants of ameloblastoma. P –VALUE <0.05 was considered significant.
Results: All samples showed positive E-Cadherin expression with moderate to strong positivity. Highest positivity was observed at the level of stellate reticulum like cells, as they are closer to invasive font. Follicular type showed maximum immunoexpression (73.6%) significantly different from 25% of acanthomatous type. P value for E-Cadherin was calculated to be 0.156.
Conclusion: E-Cadherin showed positive results in all histological subtypes of ameloblastoma with maximum intensity in follicular type and minimum in acanthomatous type.
Khyber College of Dentistry
Title: TO DETERMINE THE EXPRESSION OF E-CADHERIN IN DIFFERENT HISTOLOGICAL SUBTYPES OF AMELOBLASTOMA FOR GAUGING AND PREDICTING THE AGGRESSIVENESS AND BEHAVIOR OF THIS TUMOR IN OUR POPULATION
Description:
Objective: The current study is designed to determine the expression of immunohistochemical markers E-Cadherin in different histological subtypes of ameloblastoma for gauging and predicting the aggressiveness and behavior of this tumor in our population.
Materials and Methods: A total of 60 cases of ameloblastoma were collected for this study from June2016 to June 2017, in AFIP Rawalpindi.
The tumor was sub-classified histologically on the basis of WHO classification.
Final results were analyzed.
Mean and standard deviation were calculated for quantitative variables.
Frequency and percentages were calculated for qualitative variables.
Chi square test was applied to find the association of E-Cadherin with histological variants of ameloblastoma.
P –VALUE <0.
05 was considered significant.
Results: All samples showed positive E-Cadherin expression with moderate to strong positivity.
Highest positivity was observed at the level of stellate reticulum like cells, as they are closer to invasive font.
Follicular type showed maximum immunoexpression (73.
6%) significantly different from 25% of acanthomatous type.
P value for E-Cadherin was calculated to be 0.
156.
Conclusion: E-Cadherin showed positive results in all histological subtypes of ameloblastoma with maximum intensity in follicular type and minimum in acanthomatous type.
.
Related Results
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
Abstract
Objective: To compare and analyze the effect of N-cadherin on chondrogenic differentiation of bone marrow derived mesenchymal stem cells (BMSCs) and to explore the...
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
Effect of N-cadherin on Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells through Wnt Signaling Pathway
This study aimed to compare and analyze the effect of N-cadherin on chondrogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) and to explore the related me...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
<div>Abstract<p>Malignant transformation of melanocytes frequently coincides with alterations in epithelial cadherin (E-cadherin) expression, switching on of neural cad...
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
Data from P-Cadherin Promotes Cell-Cell Adhesion and Counteracts Invasion in Human Melanoma
<div>Abstract<p>Malignant transformation of melanocytes frequently coincides with alterations in epithelial cadherin (E-cadherin) expression, switching on of neural cad...
Clinicopathologic Profile and Surgical Modalities in Mandibular Ameloblastoma: A Descriptive Study
Clinicopathologic Profile and Surgical Modalities in Mandibular Ameloblastoma: A Descriptive Study
Background:
Ameloblastoma is a benign neoplasm composed of epithelial tissue with invasive and infiltrative behavior at the local level and a high recurrence rate, with...
Abstract 2708: E-cadherin expression might be a predictive marker for chemosensitivity in triple-negative breast cancer
Abstract 2708: E-cadherin expression might be a predictive marker for chemosensitivity in triple-negative breast cancer
Abstract
Introduction: Triple-negative breast cancer (TNBC), a subtype of breast tumor with ER negative, PR negative, and HER2 negative, shows a poor prognosis becau...

